Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON21231Not yet recruiting
Randomised, double-blind trial of sevoflurane in Emergence agitation (EA) (2 arms), sponsored by Erasmus MC. Primary endpoints: Maximum PAED score within 1 hour after stopping anesthesia and Emergence delirium incidence. Planned start Sep 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON21231.